Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This specific treatment regimen consists of a combination of nicotine replacement therapies (NRT), specifically the nicotine patch and nicotine mini-lozenge, administered over a 16-week period. The Preparation component involves starting the medication 4 weeks prior to the target quit date (pre-quit), while the Standard Duration component covers 12 weeks of treatment following the quit date. This approach is being evaluated by the University of Wisconsin, Madison, as part of the Multiphase Optimization Strategy (MOST) to optimize chronic care for smokers. Nicotine replacement therapy works by providing a controlled dose of nicotine to reduce withdrawal symptoms and cravings associated with smoking cessation, acting as an agonist at nicotinic acetylcholine receptors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Preparation Combination NRT + Standard Duration Combination NRT.